Τελευταία Νέα
Διεθνή

Nuclear shield from the cradle: Iran's global innovation saves thousands of infants with uranium technology

Nuclear shield from the cradle: Iran's global innovation saves thousands of infants with uranium technology
Iran has managed to convert nuclear technology into a powerful health tool, occupying the global lead in newborn screening.

While the world watches with bated breath the negotiations for Iran's nuclear program, an unseen medical revolution is taking place in the country's maternity hospitals. Iran has managed to convert nuclear technology into a powerful health tool, occupying the global lead in newborn screening. In a world where the atom is often identified with destruction, Iran's example reminds us that the very technology that divides global diplomacy can be the only hope for a child's life in the first hours after birth.

The achievement: 58 diagnoses with a few drops of blood

Every child born in Iran now undergoes free preventive screening for 58 hereditary metabolic disorders. The process is done between the 3rd and 5th day of life with a few drops of blood from the heel of the infant. The technology that allows this "miracle" is Tandem Mass Spectrometry (MS/MS). This is a method based directly on nuclear science, as the instruments require calibration and quality control materials produced from radioisotopes deriving from enriched uranium. The success of the program is reflected in the Fars province, which constitutes the national model, having achieved 100% coverage in newborn screening for seven consecutive years. In this region alone, 54,000 infants are examined annually in 56 specialized centers, ensuring that no child starts their life without timely diagnosis.

Why does 60% enriched uranium "heal"?

Contrary to international criticisms, Iran uses uranium enriched to 60% for the production of the isotope Molybdenum-99, which in turn produces Technetium-99m. The choice of this specific enrichment level is not accidental, as it offers a fivefold yield in the production of medical isotopes. In this way, Iran produces the same quantity of medicines while creating five times less radioactive waste, and requires much less chemical processing, therefore drastically reducing environmental and industrial costs. These isotopes are necessary for the calibration of the MS/MS machines that detect disorders before symptoms appear.

A country "model" due to genetics

The program is judged as a national necessity due to the unique genetic structure of the Iranian population, where metabolic disorders appear with twice the frequency compared to the global average. The need for this program is imperative in Iran, as the frequency of metabolic disorders is 1 in 1,000 infants, a rate more than double the global average (1 in 2,500), as established by a major epidemiological study published in 2025. The study examined 138,689 newborns who underwent screening in the Fars province during 30 months. The study identified 139 confirmed cases of hereditary metabolic disorders, recording this occurrence frequency of 1 per 1,000 newborns. One of the most important prevention situations is disability from disorders such as phenylketonuria (PKU), which if not detected in the first days, lead to irreversible brain damage. Timely intervention prevents permanent neurological damage and mental retardation, changing the fate of thousands of children each year. With the screening, the children receive a special diet and develop normally. Iran designs and produces the diagnostic kits on its own, despite international sanctions, while in 2025 it began to export this technology to countries such as Cuba.

Global superpower in nuclear medicine

By the end of 2025, Iran ranked among the top three producers of radiopharmaceuticals globally. It produces approximately 69 different diagnostic and therapeutic formulations, serving over one million patients annually. Nuclear diplomacy and "soft power": This technology now operates also as a tool of international influence. In June 2025, Iran delivered to Cuba advanced metabolic screening kits of international standards, proving that its domestic nuclear medicine has reached a level of autonomy that allows it to export expertise despite sanctions. The same technology that causes international geopolitical tension is the one that daily in Iran guarantees that thousands of children will not live with a disability, converting the atom from a "weapon" into a "medicine".

 

www.bankingnews.gr

Ρoή Ειδήσεων

Σχόλια αναγνωστών

Δείτε επίσης